Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | USP2 | O75604 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | DNMT1 | P26358 | 4/20 | 0.50 |
| ▸ | DNMT3A | Q9Y6K1 | 3/20 | 0.50 |
| ▸ | CCNC | P24863 | 1/20 | 0.49 |
| ▸ | CDK8 | P49336 | 1/20 | 0.49 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30180507 | 0.92 | KMT2A (0.80) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL19151510 | 0.92 | KMT2A (0.80) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL13335886 | 0.89 | KMT2A (0.85) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL13335888 | 0.86 | KMT2A (0.74) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL25825392 | 0.85 | DNMT1 (0.54) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL13335884 | 0.85 | MAPT (0.77) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL25825372 | 0.84 | KMT2A (0.70) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL25825387 | 0.84 | DNMT1 (0.58) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL25819890 | 0.83 | KMT2A (0.68) | KMT2AMAPTUSP2MAPK1ALDH1A1 | |
| SCHEMBL25825389 | 0.82 | DNMT1 (0.56) | KMT2AMAPTUSP2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183226-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183226-A1 | AKT3 MODULATORS | AKT3, AKT2, MTOR | KMT2A 3974/4885MAPT 3999/4885USP2 3935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.